Гастроэнтерология / 02. ХГ. ГЭРБ / ХГ / OLGA
.pdf18. Konturek P.C., Konturek S.J., Brzozowski T. Helicobacter pylori infection in gastric
cancerogenesis // J. Physiol. Pharmacol. — 2009. — Vol. 60. Р. 3-21.
19.Ramírez-Mendoza P, González-Angulo J et al. Evaluation of Gastric Atrophy. Comparison between Sidney and OLGA Systems // Rev Med Inst Mex Seguro Soc. — 2008. Vol . 46. Р. 135-
20.Rugge M., Correa Р., Di Mario F., El-Omar E , Fiocca R., Geboes K., Genta R.M. et al. OLGA staging for gastritis: A tutorial // Digestive and Liver Disease. — 2008. Vol. 40. Р. 650-658.
21.Rugge M, De Boni M, Pennelli G et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study // Aliment. Pharmacol. Ther. — 2010. Vol. 31.
Р.1104–1111.
22.Rugge M, Kim JG, Mahachai V et al. OLGA gastritis staging in Young Adults and country— specific gastric cancer risk // Int. J. Surg. Pathol. — 2008. Vol. 16. Р.150–154.
23.Rugge M, Meggio A, Pennelli G et al. Gastritis staging in clinical practice: the OLGA staging system // Gut. — 2007. Vol. 56. Р. 631–636.
24.Rugge M., Genta R.M. Staging and grading of chronic gastritis // Human Pathology. — 2005. Vol. 36. P. 228-233.
25.Satoh K, Osawa H, Yoshizawa M et al. Assessment of atrophic gastritis using the OLGA system // Helicobacter. — 2008. Vol.13. Р. 225–229.
26.Torisu T., Matsumoto T., Takata Y. Atrophic gastritis, but not antibody to Helicobacter pylori, is associated with body mass index in a Japanese population // J. Gastroenterol. — 2008. Vol. 43. Р. 762-766.
27.Vannella L., Lahner E., Osborn J. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis // Aliment. Pharmacol. Ther. — 2010. Vol. 13. Р. 94-100.
28. Yeh L.Y., Raj M., Hassan S. Chronic atrophic antral gastritis and risk of metaplasia and dysplasia in an area with low prevalence of Helicobacter pylori // Indian J. Gastroenterol. — 2009. Vol. 28. Р. 49-52.
